Patompong UngprasertPrangthip CharoenpongPraveen RatanasrimethaCharat ThongprayoonWisit CheungpasitpornPromporn SuksaranjitMahidol UniversityAdvocate Illinois Masonic Medical CenterMayo ClinicUniversity of Utah, School of Medicine2018-11-092018-11-092014-01-01Clinical Rheumatology. Vol.33, No.8 (2014), 1099-110414349949077031982-s2.0-84904425876https://repository.li.mahidol.ac.th/handle/20.500.14594/34742Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, have been shown to increase coronary artery disease (CAD) risk but the data on systemic sclerosis (SSc) is unclear. We conducted a systematic review and meta-analysis of observational studies that reported odds ratio, relative risk, hazard ratio, or standardized incidence ratio comparing CAD risk in patients with SSc versus non-SSc participants. Pooled risk ratio and 95 % confidence intervals were calculated using a random effect, generic inverse variance method. Four studies were identified and included in our data analysis. The pooled risk ratio of CAD in patients with SSc was 1.82 (95 % CI, 1.40 to 2.36). The statistical heterogeneity of this meta-analysis was moderate with an I2of 73 %. Our study demonstrated a statistically significant increased CAD risk among patients with SSc. © 2014 Clinical Rheumatology.Mahidol UniversityMedicineArticleSCOPUS10.1007/s10067-014-2681-4